UK markets closed

Easton Pharmaceuticals Inc. (EAPH)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 10:07AM EDT

Easton Pharmaceuticals Inc.

111 Brockhouse Road
Toronto, ON
Canada

https://www.eastonpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Evan KarrasCEO, President, Secretary, Treasurer, CFO & Director150kN/A1971
Dr. Lilla Albert Ph.D.Chief Marketing and Technology OfficerN/AN/AN/A
Ms. Elena MilantoniDirector of Finance and AdministrationN/AN/A1970
Mr. Neil MellorSenior Business Consultant, Special Advisor and Member of Advisory BoardN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Parallel Industries Inc. does not have significant operations. Previously, the company was involved in development and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. It focuses on development, licenses, production, and markets prescription and over-the-counter products. The company was formerly known as Easton Pharmaceuticals Inc. and changed its name to Parallel Industries Inc. in December 2020. Parallel Industries Inc. was founded in 1997 and is headquartered in Toronto, Canada.

Corporate governance

Easton Pharmaceuticals Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.